Plain-English translation of NCT06865326 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a new screening process designed to catch a condition called chronic thromboembolic pulmonary hypertension (CTEPH) early in patients who have had a pulmonary embolism — a serious blood clot in the lungs. The goal is to identify people at risk before their condition worsens and get them to a specialized center for treatment quickly. Early detection can significantly improve quality of life and prevent serious complications.
Some patients who survive a pulmonary embolism go on to develop chronic blood clots that remain in their lungs, which can be life-threatening if not caught early. This study exists to create a reliable, standardized way for doctors across the country to spot these high-risk patients and connect them with specialized pulmonary hypertension centers before it's too late.
You likely qualify if…
You likely don't qualify if…
You will visit one of approximately 10 selected hospital centers in the Czech Republic to undergo a standardized screening process designed to check whether you have developed chronic blood clots in your lungs since your pulmonary embolism. If the screening suggests you may have this condition, you will be referred to a specialized pulmonary hypertension treatment center for further evaluation and care. The study involves no experimental medication — just organized, systematic testing to ensure you get the right specialist care at the right time.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Czechia